肝转移的空间免疫重塑:发现抗转移药物治疗的途径
Wenchao Xu1,2,3,4, Yibo Wang1,2,3,4, Nanzhou Wang5
1Department of General Surgery, Peking Union Medical College Hospital, Beijing, Beijing, China.
Journal for immunotherapy of cancer
|March 19, 2025
概括
分析肝转移中的空间免疫细胞分布揭示了瘤微环境的变化. 这种空间免疫重塑的理解是开发新的抗转移治疗和改善患者预测的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 空间奥米克斯 空间奥米克斯
背景情况:
- 了解转移性瘤的特征对于开发有效的抗转移性治疗非常重要.
- 目前分析免疫细胞转录特征的方法在了解免疫逃生机制方面存在局限性.
- 空间免疫视角为研究瘤与免疫相互作用提供了更全面的方法.
研究的目的:
- 为了研究免疫细胞在肝脏转移中的空间分布.
- 在转移性瘤中探索空间免疫重塑的分子基础.
- 评估空间免疫特征对临床预测和治疗向的潜力.
主要方法:
- 利用先进的空间奥米克技术,对肝转移样本进行高通量分析.
- 检查了由转移引起的免疫细胞分布的空间变化.
- 研究了空间免疫重塑的基础分子机制.
主要成果:
- 在肝转移性瘤的不同区域确定了特定的空间免疫细胞聚合.
- 证明这些空间免疫特征会改变局部免疫环境和全球瘤行为.
- 揭示了空间免疫重塑作为瘤进展和免疫逃逸的重要因素.
结论:
- 肝转移的空间免疫分析为瘤生物学和免疫逃避提供了关键的见解.
- 识别治疗前的空间免疫特征可以导致准确的临床预测.
- 针对空间免疫重塑,为未来的抗转移性疗法提供了一个有前途的战略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


